Hemostatic abnormalities

Neonatal Hematology

Volumn , Issue , 2005, Pages 310-348

  Albisetti, Manuela ^a   Andrew, Maureen ^b   Monagle, Paul ^c  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b Women’s and Children’s Health Royal Children’s Hospital ^*

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44149109077     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545306.015     Document Type: Chapter

References (379)

1. Girolami, A., De Marco, L., Dal Bo Zanon, R., Patrassi, R., Cappellato, M. G. Rarer quantitative and qualitative abnormalities of coagulation. Clin Hematol 1985; 14: 385-411.
2. Buchanan, G.R. Coagulation disorders in the neonate. Pediatr Clin North Am 1986; 33: 203-220.
3. Montgomery, R. R., Marlar, R. A., Gill, J. C. Newborn haemostasis. Clin Hematol 1985; 14: 443-460.
4. Gibson, B. Neonatal haemostasis. Arch Dis Child 1989; 64: 503-506.
5. Lopez-Fernandez, M. F., Blanco-Lopez, M. J., Castineira, M. P, Batlle, J. Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII. Am J Hematol 1992; 40: 20-27.
6. Eikenboom, J. C., Reitsma, P H., Peerlinck, K. M., Briet, E. Recessive inheritance of von Willebrand’s disease type I. Lancet 1993; 341: 982-986.
7. Mazzone, D., Fichera, A., Pratico, G., Sciacca, F. Combined congenital deficiency of factor V and factor VIII. Acta Haematol 1982; 68: 337-338.
8. McMillan, C., Roberts, H. Congenital combined deficiency of coagulation factors II, VII, IX and X. N Engl J Med 1966; 274: 1313-1315.
9. Silverstein, A. Intracranial bleeding in hemophilia. Arch Neurol 1960; 3:141-157.
10. Yoffe, G., Buchanan, G. R. Intracranial haemorrhage in newborn and young infants with hemophilia. J Pediatr 1988;113:333-336.
11. Abbondanzo, S. L., Gootenberg, J. E., Lofts, R. S., McPherson, R. A. Intracranial hemorrhage in congenital deficiency of factor XIII. Am J Pediatr Hematol Oncol 1988; 10: 65-68.
12. Struwe, F. Intracranial hemorrhage and occlusive hydrocephalus in hereditary bleeding disorders. Dev Med Child Neurol 1970; 12:165-169.
13. Mariani, G., Mazzucconi, M. G. Factor VII congenital deficiency: clinical picture and classification of the variants. Haemostasis 1983; 13: 169-177.
14. Baehner, R. L., Strauss, H. Hemophilia in the first year of life. N Engl J Med 1966; 275: 524-528.
15. Seligsohn, U., Shani, M., Ramot, B. Gilbert syndrome and factor-VII deficiency. Lancet 1970; 1:1398.
16. Levanon, M., Rimon, S., Shani, M., Ramot, B., Goldberg, E. Active and inactive factor VII in Dubin-Johnson syndrome with factor-VII deficiency, hereditary factor-VII deficiency and on coumadin administration. Br J Haematol 1972; 23: 669-677.
17. Andrew, M., Paes, B., Milner, R., et al. Development of the human coagulation system in the full-term infant. Blood 1987;70:165-172.
18. Andrew, M., Paes, B., Milner, R., et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72:1651-1657.
19. Andrew, M., Paes, B., Johnston, M. Development of the hemostatic system in the neonate and young infant. Am J PediatrHematol Oncol 1990; 12:95-104.
20. Ylikorkala, O., Halmesmaki, E., Viinikka, L. Effect of ethanolon thromboxane and prostacyclin synthesisbyfetal platelets and umbilical artery. Life Sci 1987; 41: 371-376.
21. Forestier, F, Daffos, F, Sole, Y., Rainaut, M. Prenatal diagnosis of hemophilia by fetal blood sampling under ultrasound guidance. Haemostasis 1986; 16:346-351.
22. Killick, C. J., Barton, C. J., Aslam, S., Standen, G. Prenatal diagnosis in factor XIII-A deficiency. Arch Dis Child Fetal NeonatalEd 1999; 80: F238-F239.
23. Antonarakis, S. E., Copeland, K. L., Carpenter, R. J., etal.Prenatal diagnosis of haemophilia A by factor VIII gene analysis. Lancet 1985; 1: 1407-1409.
24. Peake, I. R., Bowen, D., Bignell, P., et al. Family studies and prenataldiagnosisinseverevonWillebranddiseasebypoly- merase chain reaction amplification of a variable number tandem repeat region of the von Willebrand factor gene. Blood 1990; 76: 555-561.
25. Schulman, I. Pediatric aspects of the mild hemophilias. Med Clin NorthAm 1962; 46: 93-105.
26. Kozinn, P., Ritz, N., Moss, A., Kaufman, A. Massive hemorrhage: scalps of newborn infants. Am J Dis Child 1964; 108: 413-417.
27. Kozinn, P., Ritz, N., Horowitz, A. Scalp hemorrhage as an emergency in the newborn. J Am Med Assoc 1965; 194: 179-180.
28. McCarthy, J., Coble, L. Intracranial hemorrhage and subsequent communicating hydrocephalus in a neonate with classical hemophilia. J Pediatr 1973; 51:122-124.
29. Bray, G. L., Luhan, N. Hemophilia presenting with intracranial hemorrhage. Am J Dis Child 1987; 141: 1215-1217.
30. Pollman, H., Richter, H., Ringkamp, H., Jurgens, H. When are children diagnosed as having severe haemophilia and when do they start to bleed? A 10 year single centre PUP study. Eur J Pediatr 1999; 158: S166-S170.
31. Klinge, J., Auberger, K., Auerswald, G., et al. Prevalence and outcome of intracranial haemorrhage in haemophiliacs: a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH). Eur J Pediatr 1999; 158: S162-S165.
32. Kulkarni, R., Lusher, J. M. Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature. J Pediatr Hematol Oncol 1999; 21:289-295.
33. Le Pommelet, C., Durand, P, Laurian, Y., Devictor, D. Haemophilia A: two cases showing unusual features at birth. Haemophilia 1998; 4:122-125.
34. Johnson-Robbins, L. A., Porter, J. C., Horgan, M. J. Splenic rupture in a newborn with hemophilia A: case report and review of the literature. Clin Pediatr (Phila) 1999; 38: 117-119.
35. Fields, J. M., Saluja, S., Schwartz, D. S., Touloukian, R. J., Keller, M. S. Hemophilia presenting in an infant as a radial artery pseudoaneurysm following arterial puncture. Pediatr Radiol 1997;27: 763-764.
36. DiMichele, D., Neufeld, E. J. Hemophilia: a new approach to an old disease. Hematol Oncol Clin North Am 1998; 12: 1315-1344.
37. Martinowitz, U., Varon, D., Jonas, R, et al. Circumcision in hemophilia: the use of fibrin glue for local hemostasis. J Urol 1992; 148: 855-857.
38. Wiltgen, C. W., Hasegawa, D. Hamophilia B: case studyand intervention plan. J Obstet Gynecol Neonatal Nurs 1983; 12: 82-85.
39. Schwartz, I., Root, A. Hypercalcemia associated with normal I125-dihydroxyvitamin D concentrations in a neonate with factor IXdeficiency. J Pediatr 1989; 114: 509-510.
40. Pegelow, C. H., Borromeo, M. C., Daghastani, D., Band- stra, E. S. Plasma support for surgery in a premature infant with factor IX deficiency. Am J Dis Child 1989; 143: 639-640.
41. Kletzel, M., Miller, C. H., Becton, D. L., Chadduck, W. M., Elser, J. M. Postdelivery headbleeding in hemophilic neonates: causes and management. Am J Dis Child 1989; 143:1107-1110.
42. Stowell, K., Figueiredo, M., Brownlee, G., Jones, P, Bolton- Maggs, P H. B. HaemophiliaBLiverpool: anewBritishfamily with mild haemophilia B associated with a -6 G to A mutation in the factor IX promoter. Br J Haematol 1993; 85: 188-190.
43. Hartmann, J., Diamond, L. Hemophilia and related hemorrhagic disorders. Practitioner 1957; 178:179-190.
44. Ljung, R., Petrini, P., Nilsson, I. Diagnostic symptoms of severe and moderate haemophilia A and B. Acta Paediatr Scand 1990; 79:196-200.
45. Manios, S., Schenck, W., Kunzer, W. Congenital fibrinogen deficiency. Acta Pediatr Scand 1968; 57: 145-180.
46. Lewis, J., Spero, J., Ragni, M., Bontempo, F. A. Transfusion support for congenital clotting deficiencies other than haemophilia. Clin Hematol 1984; 13: 119-135.
47. Zenny, J., Chevrot, A., Sultan, Y., et al. Lesions hemorrag- iques intra-osseuses des afibrinemies congenitales: a propos d’un nouveau cas. J Radiol 1981:62:263-266.
48. Fried, K., Kaufman, S. Congenital afibrinogenemia in 10 offspring of uncle-niece marriages. Clin Genet 1980; 17: 223-227.
49. Gill, F., Shapiro, S., Schwartz, E. Severe congenital hypopro- thrombinemia. J Pediatr 1978; 93:264-266.
50. Viola, L., Chiaretti, A., Lazzareschi, I., etal.Intracranialhem-orrhage in congenital factor II deficiency. Pediatr Med Chir 1995; 17: 593-594.
51. Seeler, R. Parahemophilia. Factor V deficiency. Med Clin NorthAm 1972; 56:119-125.
52. Daffos, F., Forestier, F., Kaplan, C., Cox, W. Prenatal diagnosis and management of bleeding disorders with fetal blood sampling. AmJ Obstet Gynecol 1988; 158: 939-946.
53. Salooja, N., Martin, P., Khair, K., Liesner, R., Hann, I. Severe factorVdeficiencyand neonatal intracranial haemorrhage: a case report. Haemophilia 2000; 6: 44-46.
54. Ehrenforth, S., Klarmann, D., Zabel, B., Scharrer, I., Kreuz, W. Severe factor V deficiency presenting as subdural haematoma in the newborn. Eur J Pediatr 1998; 157: 1032.
55. Kashyap, R., Saxena, R., Choudhry, V P. Rare inherited coagulation disorders in India. Haematologia (Budap) 1996; 28: 13-19.
56. Whitelaw, A., Haines, M., Bolsover, W., et al. Factor V deficiency and antenatal ventricular hemorrhage. Arch Dis Child 1984; 59:997-999.
57. Bonvini, G., Cotta-Ramusino, A., Ricciardi, G. Congenital factorVdeficiencyandintraventricularhemorrhageof pre- natal origin. Pediatr Med Chir 1994; 16: 93-94.
58. Rabiner, S., Winick, M., Smith, C. Congenital deficiency of factor VII associated with hemorrhagic disease Of the newborn. Pediatrics 1960;25:101-105.
59. Matthay, K., Koerper, M., Ablin, A. R. Intracranial hemorrhage in congenital factor VII deficiency. J Pediatr 1979; 94: 413-415.
60. Schubert, B., Schindera, F. Congenital factor VII deficiency inanewborn (abstr). Hamophilie-Symposion 1988.
61. Ragni, M., Lewis, J., Spero, J., etal. FactorVII deficiency. Am J Hematol 1981;10: 79-88.
62. Seligsohn, U., Shani, M., Ramot, B. Dubin-Johnston syndrome in Israel: association with factor VII deficiency. Q J Med 1970; 39: 569-584.
63. Worth, L. L., Hoots, W. K. Development of a subdural vein thrombosis following aggressive factor VII replacement for postnatalintracranialhaemorrhageinahomozygousfactor VII-deficient infant. Haemophilia 1998;4:757-761.
64. Wong, W. Y., Huang, W. C., Miller, R., McGinty, K., Whisnant, J. K. Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency. Haemophilia 2000; 6: 50-54.
65. Katz, J. A., Moake, J. L., McPherson, P D., et al. Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma. Blood 1989; 73:1851-1858.
66. Weinstein, M. J., Blanchard, R., Moake, J. L., Vosburgh, E., Moise, K. Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura. Br J Haematol 1989; 72: 68-72.
67. Donner, M., Holmberg, L., Nilsson, I. M. Type IIB vonWille- brand’s disease with probable autosomal recessive inheritance and presenting as thrombocytopenia in infancy. Br J Haematol 1987; 66: 349-354.
68. Bignall, P., Standen, G., Bowen, D. J., Peake, I., Bloom, A. L. Rapid neonatal diagnosis of von Willebrand’s disease by use of the polymerase chain reaction. Lancet 1990; 336:638-639.
69. Gazengel, C., Fischer, A., Schlegel, N., et al. Treatment of type III von Willebrand’s disease with solvent/detergent- treated factor VIII concentrates. Nouv Rev Fr Hematol 1988; 30: 225-227.
70. Lopez-Fernandez, M. F., Lopez-Berges, C., Corral, M., etal. Assessment of multimeric structure and ristocetin-induced binding to platelets of von Willebrand factor present in cry- oprecipitateanddifferentfactorVIII concentrates. Vox Sang 1987; 52:15-19.
71. Machin, S., Winter, M., Davies, S., Mackie, I. FactorXdefi-ciency in the neonatal period. Arch Dis Child 1980; 55: 406-408.
72. Sandler, E., Gross, S. Prevention of recurrent intracranial hemorrhage in a factor X deficient infant. Am J Pediatr Hematol Oncol 1992; 14:163-165.
73. Ruane, B., McCord, F. Factor X deficiency: a rare cause of scrotalhaemorrhage. Irish Med J 1990; 83:163.
74. El Kalla, S., Menon, N. S. Neonatal congenital FactorXdefi- ciency. Pediatr Hematol Oncol 1991; 8: 347-354.
75. De Sousa, C., Clark, T., Bradshaw, A. Antenatally diagnosed subdural haemorrhage in congenital factor X deficiency. Arch Dis Child 1988; 63:1168-1174.
76. Edson, J. R., White, J. G., Krivit, W. The enigma of severe factor XI deficiency without hemorrhagic symptoms: distinction from Hageman factor and “Fletcher factor” deficiency; family study; and problems of diagnosis. Thromb Diath Haemorrh 1967; 18: 342-348.
77. Kitchens, C. FactorXI:areviewofitsbiochemistryand deficiency. Semin Thromb Haemost 1991; 17:55-72.
78. Barozzino, T., Sgro, M., Toi, A., et al. Fetal bilateral subdural haemorrhages: prenatal diagnosis and spontaneous resolutionbytime of delivery. Prenat Diagn 1998; 18:496-503.
79. Duckert, F., Jung, E., Shmerling, D. Hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency.Thromb Diath Haemorrh 1960; 5: 179.
80. Barry, A., Delage, M. Congenital deficiency of fibrin stabilizing factor: observation of a new case. N Engl J Med 1965; 272: 943-946.
81. Fisher, S., Rikover, M., Naor, S. Factor 13 deficiency with severe hemorrhage diathesis. Blood 1966; 28:34-9.
82. Britten, A. F. H. Congenital deficiency of factor 13 (fibrin- stabilizing factor): report of a case and review of the literature. Am J Med 1967; 43: 751-761.
83. Ozsoylu, S., Altay, C., Hi csonmez, G. Congenital factor XIII deficiency: Observationoftwocasesinthe newbornperiod. Am JDis Child 1971;122: 541-543.
84. Francis, J., Todd, P. Congenital factor XIII deficiency in a neonate. Br Med J 1978;2:1532.
85. Merchant, R., Agarwal, B. R., Currimbhoy, Z., Pherwani, A., Avasthi, B. Congenital factor XIII deficiency. Ind Pediatr 1992; 29:831-836.
86. Solves, P., Altes, A., Ginovart, G., Demestre, J., Fontcu- berta, J. Late hemorrhagic disease of the newborn as a cause of intracerebral bleeding. Ann Hematol 1997; 75:65-66.
87. Seitz, R., Duckert, F., Lopaciuk, S., etal. ETRO Working Party on FactorXIII questionnaire oncongenital factorXIII deficiency in Europe: status and perspectives. Semin Thromb Hemost 1996; 22: 415-418.
88. Blanckaert, D., Oueidat, I., Chelala, J., Loeuille, G. A., Delepoulle, F.Congenitaldeficiencyoffibrinstabilizingfac-tor (factorXIII). Pediatrie 1993; 48: 451-453.
89. Daly, H. M., Haddon, M. E. Clinical experience with a pasteurised human plasma concentrate in factor XIII deficiency. Thromb Haemost 1988; 59:171-174.
90. Landman, J., Creter, D., Homburg, R., Sirota, L., Dulitzky, F. Neonatal factor XIII deficiency. Clin Pediatr (Phila) 1985; 24: 352-353.
91. Duckert, F. Documentation of the plasma factor XIII defi- ciencyinman. Ann NYA cad Sci 1972; 202:190-199.
92. Gootenberg, J. E. Factor concentrates for the treatment of factorXIII deficiency. Curr Opin Hematol 1998; 5:372-375.
93. Mammen, E., Murano, G., Bick, R. L. Combined congenital clotting factor abnormalities.Semin Thromb Haemost 1983; 9: 55-56.
94. Sharland, M., Patton, M. A., Talbot, S., Chitolie, A., Bevan, D. H. Coagulation-factor deficiencies and abnormal bleeding in Noonan’s syndrome. Lancet 1992; 339:19-21.
95. Yoshioka, A., Kamitsuji, H., Takase, T., et al. Congenital deficiency of alpha-2-plasmin inhibitor in three sisters. Haemostasis 1982; 11:176-184.
96. Leebeek, F. W., Stibbe, J., Knot, E. A., et al. Mild haemostatic problems associatedwith congenital heterozygous alpha2- antiplasmin deficiency. Thromb Haemost 1988; 59:96-100.
97. Kordich, L., Feldman, L., Porterie, P, Lago, O. Severe hemorrhagic tendencyinheterozygousalpha-2-antiplasmin deficiency. Thromb Res 1985:40:645-651.
98. Kettle, P, Mayne, E. E.Ableeding disorder due to deficiency of alpha-2-antiplasmin. J Clin Pathol 1985; 38: 428-429.
99. Miles, L. A., Plow, E. F., Donnelly, K. J., Hougie, C., Griffin, J. H.Ableeding disorder due to deficiencyof alpha- 2-antiplasmin. Blood 1982; 59:1246-1251.
100. Kluft, C., Vellenga, A., Brommer, E. J. P., Wijngaards, G. A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha-2-antiplasmin. Blood 1982; 59:1169-1180.
101. Devaussuzenet, V. M. P., Ducou-le-Pointe, H. A., Doco, A. M., et al. A case of intramedullary haematoma associated with congenital alpha2-plasmin inhibitor deficiency. Pediatr Radiol 1998; 28: 978-980.
102. Schwartz, B. S., Williams, E. C., Conlan, M. G., Mosher, D.F.Epsilon-aminocaproicacidinthetreatmentof patients with acute promyelocytic leukemia and acquired alpha- 2-plasmin inhibitor deficiency. Ann Intern Med 1986; 105: 873-877.
103. Zarnovicanova, M., Mocikova, K. A homozygous quantitative defect of alpha 2-antiplasmin in a family from central Slovakia. Bratisl Lek Listy 2000; 101: 28-30.
104. Mandelbrot, L., Guillaumont, M., Forestier, F., et al. Placental transfer of vitamin K1 and its implications in fetal haemostasis. Thromb Haemost 1988; 60: 39-43.
105. Shearer, M. J., Barkhan, P, Rahim, S., Stimmler, L. Plasma vitamin K1 in mothers and their newborn babies. Lancet 1982; 2: 460-463.
106. Greer, F. R., Mummah-Schendel, L. L., Marshall, S., Suttie, J. W. Vitamin K1 (phylloquinone) and vitamin K2 (menaquinone) status in newborns during the first week of life. Pediatrics 1988; 81:137-140.
107. Hiraike, H., Kimura, M., Itokawa, Y. Determination of K vitamins (phylloquinone and menaquinones) in umbilical cord plasma by a platinum-reduction column. J Chromotogr 1988; 430:143-148.
108. Hiraike, H., Kimura, M., Itokawa, Y. Distribution of K vitamins (phylloquinone and menaquinones) in human placenta and maternal and umbilical cord plasma. Am J Obstet Gynecol 1988; 158: 564-569.
109. Srinivasan, G., Seeler, R. A., Tiruvury, A., Pildes, R. S. Maternal anticonvulsant therapy and hemorrhagic disease of the newborn. Obstet Gynecol 1982; 59: 250-252.
110. Mountain, K. R., Hirsh, J., Gallius, A. S. Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy. Lancet 1970; 1: 265-268.
111. Laosombat, V. Hemorrhagic disease of the newborn after maternal anticonvulsant therapy: a case report and literature review. J Med Assoc Thailand 1988; 71:643-648.
112. Eggermont, E., Logghe, N., Van De Casseye, W., et al. Haemorrhagic disease of the newborn in the offspring of rifampicin and isoniazid treated mothers. Acta Paediatr Belg 1976; 29:87-90.
113. Sutor, A. H., Von Kries, R., Cornelissen, E. A., McNinch, A. W., Andrew, M. Vitamin K deficiency bleeding (VKDB) in infancy. ISTH Pediatric/Perinatal Subcommittee. International Society on Thrombosis and Haemostasis. Thromb Haemost 1999; 81: 456-461.
114. Widdershoven, J., Motohara, K., Endo, F., Matsuda, I., Monnens, L. Influence of the type of feedingonthepresence of PIVKA-II in infants. Helv Paediatr Acta 1986; 41:25-29.
115. Editorial. Late onset of hemorrhagic disease of the newborn. Nutr Rev 1985; 43: 303.
116. Matsuda, I., Nishiyama, S., Motohara, K., etal. Late neonatal vitamin K deficiency associated with subclinical liver dysfunction in human milk fed infants. J Pediatr 1989; 114: 602-605.
117. Goldschmidt, B., Bors, S., Szabo, A. Vitamin K-dependent clotting factors during longterm parenteral nutrition in full- term and preterm infants. J Pediatr 1988;112:108-111.
118. Motohara, K., Endo, F., Matsuda, I. Screening for late neonatal vitamin K deficiency by acarboxyprothrombin in dried blood spots. Arch Dis Child 1987; 62: 370-375.
119. Forbes, D. Delayed presentation of haemorrhagic disease of the newborn. Med JAust 1983; 2:136-138.
120. Payne, N. R., Hasegawa, D. K. Vitamin K deficiency in newborns: a case report in a-1-antitrypsin deficiency and a review of factors predisposing to hemorrhage. Pediatrics 1984; 73:712-716.
121. Chaou, W.-T., Chou, M.-L., Eitzman, D. V. Intracranial hemorrhage and vitamin K deficiency in early infancy. J Pediatr 1984; 105:880-884.
122. Corrigan, J. J., Jr, Earnest, D. Factor II antigen in liver disease and warfarin-induced vitamin K deficiency: correlation with coagulation activity using Echis venom. Am JHaematol 1980; 8: 249-255.
123. Martin-Bouyer, G., Linh, P. D., Tuan, L. C. Epidemic of haem- orrhagic disease inVietnamese infants caused bywarfarin- contaminated talcs. Lancet 1983; 1:230-233.
124. Motohara, K., Kuroki, Y., Kan, H., Endo, F., Matsuda, I. Detection of vitamin K deficiency by use of an enzyme- linked immunosorbent assayfor circulating abnormal prothrombin. PediatrRes 1985;19: 354-357.
125. Vietti, T. J., Murphy, T. P, James, J. A., Pritchard, J. A. Observation on the prophylactic use of vitamin K in the newborn. J Pediatr 1960; 56: 343-346.
126. Sutherland, J. M., Glueck, H. I. Hemorrhagic disease of the newborn: breast feeding as a necessaryfactor in the pathogenesis. Am J Dis Child 1967; 113: 524-533.
127. Vietti, T. J., Stephens, J. C., Bennett, K. R. Vitamin K-1 prophylaxis inthe newborn. J Am Med Assoc 1961;176:791.
128. Widdershoven, J., Lambert, W., Motohara, K., etal. Plasma concentrations of vitamin K1 and PIVKA-II inbottle-fed and breast-fed infants with and without vitamin K prophylaxis atbirth. Eur J Pediatr 1988; 148:139-142.
129. Ogata, T., Motohara, K., Endo, F., et al. Vitamin K effect in low birth weight infants. Pediatrics 1988; 81: 423-427.
130. Von Kries, R., Kreppel, S., Becker, A., Gobel, U., Tanger-mann, R. Acarboxyprothrombin activity after oral prophylactic vitamin K. ArchDis Child 1987; 62:938-940.
131. Waddell, W. W., Guerry, D. The role of vitamin K in the etiology, prevention, and treatment of hemorrhage in the newborn infant: part II. JPediatr 1939; 15:802.
132. Hanawa, Y., Maki, M., Murata, B., etal. The second nationwide survey in Japan of vitamin K deficiency in infants. Eur JPediatr 1988; 147: 472-477.
133. Golding, J., Greenwood, R., Birmingham, K., Mott, M.Child-hood cancer, intramuscular vitamin K, and pethidine given during labour. Br Med J 1992; 305: 341-346.
134. Von Kries, R., Gobel, U. Vitamin K prophylaxis and vitamin Kdeficiencybleeding (VKDB) in earlyinfancy ActaPaediatr 1992;81:655-657.
135. Tonz, O., Schubiger, G. Neonatal vitamin K prophylaxis and vitamin K deficiency hemorrhages in Switzerland 1986-1988. Schweiz Med Wochenschr 1988; 118: 1747-1752.
136. Cornelissen, E. A. M., Kollee, L. A. A., van Lith, T. G. P. J., Motohara, K., Monnens, L. A. H. Evaluation of a daily dose of 25 g Vitamin K1 to prevent vitamin K deficiency in breast-fed infants. J Pediatr Gastroenterol Nutr 1993; 16: 301-305.
137. Cornelissen, M., Von Kries, R., Loughnan, P., Schubiger, G. Preventionof vitaminKdeficiencybleeding:efficacyof dif- ferent multiple oral dose schedules of vitamin K. Eur J Pediatr 1997; 156:126-130.
138. Greer, F. R., Marshall, S. R, Severson, R. R., et al. A new mixed micellar preparation for oral vitamin K prophylaxis: randomised controlled comparison with an intramuscular formulation in breast fed infants. Arch Dis Child 1998; 79: 300-305.
139. Schubiger, G., Stocker, C., Banziger, O., Laubscher, B., Zim- mermann, H. Oral vitamin K1 prophylaxis for newborns with a new mixed-micellar preparation of phylloquinone: 3 years experience in Switzerland. Eur J Pediatr 1999; 158: 599-602.
140. Levi, M., ten Cate, H. Disseminated intravascular coagulation. N Engl J Med 1999; 341:586-592.
141. Andrew, M. Developmental hemostasis: relevance to newborns and infants. In Nathan, D. G., Orkin, S. H., eds. HematologyofInfancy and Childhood, Vol.1. Philadelphia: W. B. Saunders, 1998: 114-157.
142. Abildgaard, C. F. Recognitionandtreatmentofintravasular coagulation. J Pediatr 1969; 74: 163-176.
143. Anderson, J., Brown, J. K., Cockburn, F. On the role of disseminated intravascular coagulation on the pathology of birth asphyxia. Dev Med Child Neurol 1974; 16: 581-591.
144. Chessells, J., Wigglesworth, J. Coagulation studies in severe birth asphyxia. Arch Dis Child 1971; 46:253-256.
145. Suarez, C. R., Menendez, C. E., Walenga, J. M., Fareed, J. Neonatal and maternal hemostasis: value of molecular markers in the assessment of hemostatic status. Semin Thromb Hemost 1984; 10: 280-284.
146. Yuen, P. M., Yin, J. A., Lao, T. T. Fibrinopeptide A levels in maternal and newborn plasma. Eur J Obstet Gynecol Reprod Biol 1989; 30: 239-244.
147. Suarez, C. R., Walenga, J., Mangogna, L. C., Fareed, J. Neonatal and maternal fibrinolysis: activation at time of birth. Am J Hematol 1985; 19: 365-372.
148. Ettingshausen, C. E., Veldmann, A., Beeg, T., et al. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura ful- minans. Semin Thromb Hemost 1999; 25: 537-541.
149. Rintala, E., Kauppila, M., Seppala, O. P, etal. Protein C substitution in sepsis-associated purpura fulminans. Crit Care Med 2000; 28: 2373-2378.
150. Hunter, J. Heparin therapy in meningococcal septicaemia. ArchDis Child 1973; 48: 233-235.
151. Haneberg, B., Gutteberg, T. J., Moe, P. J., et al. Heparin for infants and children with meningococcal septicemia: results of a randomized therapeutic trial. NIPH Ann 1983; 6: 43-47.
152. Blum, D., Fondu, P., Denolin-Reubens, R., Dubois, J. Early heparin therapy in 60 children with acute meningococ- cemia: relationship between clinical manifestations and coagulation abnormalities. Acta Chir Belg 1973; 4: 288-297.
153. Hathaway, W. E. Heparin therapy in acute meningococ- cemia. J Pediatr 1991; 82: 900-901.
154. Chessells, J., Wigglesworth, J. Coagulation studies in preterm infants with respiratory distress and intracranial hemorrhage. Arch Dis Child 1972; 47:564-570.
155. Corrigan, J. Activation of coagulation and disseminated intravascular coagulation in the newborn. Am J Pediatr Hematol Oncol 1979; 1:245-249.
156. Dudley, D. K., D’Alton, M. E. Single fetal death in twin gestation. Semin Perinatol 1986; 10: 65-72.
157. Chuansumrit, A., Manco-Johnson, M. J., Hathaway, W. E. Heparin cof actor II in adults and infants with thrombosis and DIC. Am J Haematol 1989; 31:109-113.
158. Schmidt, B. K., Muraji, T., Zipursky, A. Low antithrombin III in neonatal shock: DIC or non-specific protein depletion? Eur J Pediatr 1986; 145:50-03.
159. Turner, T., Prouse, C., Prescott, R., Cash, J. D.Aclinicaltrial on the early detection and correction of hemostatic defects in selected high-risk neonates. Br J Haematol 1981; 47: 65-75.
160. Beverley, D. W., Pitts-Tucker, T., Congdon, J., Arthur, R. J., Tate, I. Prevention of intra ventricular haemorrhage by fresh frozen plasma. ArchDis Child 1985;60:710-713.
161. Hambleton, G., Appleyard, W. J. Controlled trial of fresh frozen plasma in asphyxiated low birthweight infants. Arch Dis Child 1973; 48:31-35.
162. Snydor, M. S., Weaver, R. L., Johnson, C. A. Effects of fresh frozen plasma infusions on coagulation screening tests in sick neonates. PediatrRes 1977;11:542.
163. Gobel, U., vonVoss, H., Jurgens, H., etal. Efficiency of heparin in the treatment of newborn infants with respiratory distress syndrome and disseminated intravascular coagulation. Eur J Pediatr 1980; 133: 47-49.
164. Gross, S., Filston, H., Anderson, J. C. Controlled study of treatmentfordisseminatedintravascularcoagulationinthe neonate. J Pediatr 1982; 100: 445-448.
165. Kawada, Y., Shiiki, M., Miyagawa, T., et al. Successful treatment of an infant with fulminant hepatitis by factor VII concentrate. Rinsho Ketsueki 1989; 30: 1982-1986.
166. Hedner, U., Glazer, S., Falch, J. Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders. Transfus Med Rev 1993; 7: 78-83.
167. Ekert, H., Gilchrist, G., Stanton, R., Hammond, D. Hemostasis in cyanotic congenital heart disease. J Pediatr 1970; 76: 221-230.
168. Komp, D. M., Sparrow, A. W. Polycythemiaincyanotic heart disease: a study of altered coagulation. J Pediatr 1970; 76: 231-236.
169. Ware, J. A., Reaves, W. H., Horak, J. K., Solis, R. T. Defective platelet aggregation in patients undergoing surgical repair of cyanotic congenital heart disease. Ann Thorac Surg 1983; 36: 289-294.
170. Ekert, H., Dowling, S. V. Platelet release abnormality and reduced prothrombin levels in children with cyanotic congenital heart disease. Aust Paediatr J 1977; 13: 17-21.
171. Chan, A. K. C., Leaker, M., Burrows, F. A., et al. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass. Thromb Haemost 1997; 77: 270-277.
172. Watson, J. W., Brown, D. M., Lally, K. P, Null, D., Clark, R. Complications of extracorporeal membrane oxygenation in neonates. South Med J 1990; 83: 1262-1265.
173. Zavadil, D. P, Stammers, A. H., Willett, L. D., et al. Hematological abnormalities in neonatal patients treated with extracorporeal membrane oxygenation (ECMO). J Extra Corpor Technol 1998; 30: 83-90.
174. Jarjour, I., Ahdab-Barmada, M. Cerebrovascular lesions in infants and children dying after extracorporeal membrane oxygenation. Pediatr Neurol 1994; 10: 13-19.
175. Canady, A. I., Fessler, R. D., Klein, M. D. Ultrasound abnormalities in term infants on ECMO. Pediatr Neurosurg 1993; 19: 202-205.
176. McManus, M., Kevy, S., Bower, L. K., Hickey, P. Coagulation factor deficiencies during initiation of extracorporeal membrane oxygenation. J Pediatr 1995; 126:900-904.
177. Cheung, P Y., Sawicki, G., Salas, E., et al. The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates. Crit Care Med 2000; 28: 2584-2590.
178. Hardart, G. E., Fackler, J. C. Predictors of intracranial hemorrhage during neonatal extracorporeal membrane oxygenation. J Pediatr 1999; 134: 156-159.
179. Hayden, C. K., Shattuck, K. E., Richardson, C. J., et al. Subependymal germinal matrix hemorrhage in fullterm neonates. Pediatrics 1985;75:714-718.
180. Scher, M.S., Wright, F.S., Lockman, L. A., Thompson, T. R. Intraventricular hemorrhage in the full-term neonate. Arch Neurol 1982; 39: 769-772.
181. Jackson, J. C., Blumhagen, J. D. Congenital hydrocephalus due to prenatal intracranial hemorrhage. Pediatrics 1983; 72: 344-346.
182. Serfontein, G. L., Rom, S., Stein, S. Posterior fossa subdural hemorrhage in the newborn. Pediatrics 1980; 65: 40-43.
183. Gunn, T. R., Mok, P M., Becroft, D. M. Subdural hemorrhage in utero. Pediatrics 1985; 76:605-610.
184. Cartwright, G. W., Culbertson, K., Schreiner, R. L., Garg, B. P. Changes in clinical presentation of term infants with intracranial hemorrhage. Dev Med Child Neurol 1979; 21: 730-737.
185. Palma, P. A., Miner, M. E., Morriss, F. H., Jr, Adcock, E. W., 3rd, Denson, S. E. Intraventricular hemorrhage in the neonate at term. Am JDis Child 1979; 133: 941-944.
186. Chaplin, E. R., Jr, Goldstein, G. W., Norman, D. Neonatal seizures, intracerebral hematoma, and subarachnoid hemorrhage in full-term infants. Pediatrics 1979; 63: 812-815.
187. Guekos-Thoeni, U., Boltshauser, E., Willi, U. V. Intraventricular hemorrhage in full-term neonates. Dev Med Child Neurol 1982; 24: 704-705.
188. MacKay, R. J., de Crespigny, L., Murton, L. J., Roy, R. N. Intraventricular hemorrhage in term neonates: diagnosis by ultrasound. Aust Paediatr J 1984;18:205-207.
189. White, L. W. CTbrain scanningin neonates: indications and practices. Appl Radiol 1979; 8: 58-62.
190. Bejar, R., Curbelo, V., Coen, R. W., et al. Diagnosis and follow-up of intraventricular and intracerebral hemorrhages by ultrasound studies of infant’s brain through the fontanelles and sutures. Pediatrics 1980; 66: 661-673.
191. Mack, L. A., Wright, K., Hirsch, J. H., etal. Intracranial hem- orrhageinpremature infants: accuracyin sonographic evaluation. Am J Roentgenol 1981;137: 245-250.
192. Pape, K. E., Bennett-Britton, S., Szymonowicz, W., et al. Diagnostic accuracy of neonatal brain imaging: A postmortem correlation of computed tomography and ultrasound scans. J Pediatr 1983; 102: 275-280.
193. Antoniuk, S., da Silva, R. V. Periventricular and intraventricular hemorrhage in the premature infant. Rev Neurol 2000; 31: 238-243.
194. Shankaran, S., Papil, L. A., Wright, L. L., et al. The effect of antenatal phenobarbital therapy on neonatal intracranial hemorrhage in preterm infants. N Engl J Med 1997; 337: 466-471.
195. Graziani, L. J., Pasto, M., Stanley, C., etal.Cranialultrasound and clinical studies in preterm infants. J Pediatr 1985; 106:269-276.
196. Sinha, S. K., Davies, J. M., Sims, D. G., Chiswick, M. L. Relation between periventricular haemorrhage and ischaemic brain lesions diagnosed by ultrasound in very pre-term infants. Lancet 1985; 2: 1154-1156.
197. Dubowitz, L. M., Levene, M. I., Morante, A., Palmer, P., Dubowitz, V. Neurologic signs in neonatal intraventricular hemorrhage: a correlation with real-time ultrasound. J Pediatr 1981;99:127-133.
198. Perlman, J. M., Nelson, J. S., McAlister, W. H., Volpe, J. J. Intracerebellar hemorrhage in a premature newborn: diag- nosisbyreal-time ultrasound and correlationwith autopsy findings. Pediatrics 1983; 71:159-162.
199. Dolfin, T., Skidmore, M. B., Fong, K. W., Hoskins, E.M., Shennan, A. T. Incidence, severity and timing of subependymal and intraventricular hemorrhages in preterm infants born inaperinatalunitasdetectedbyserialreal-timeultrasound. Pediatrics 1983; 71: 541-546.
200. Trounce, J. Q., Fagan, D., Levene, M. I. Intraventricular haemorrhage and periventricular leucomalacia: ultrasound and autopsy correlation. Arch Dis Child 1986; 61: 1203-1207.
201. Menkes, J. H. Intracranial hemorrhage: pathogenesis and pathology. In Taeusch, H. W., Ballard, R. A., Avery, M. E., eds. Diseaseof the Newborn. Philadelphia: W. B. Saunders, 1991:422-425.
202. Goddard-Finegold, J.Periventricular, intraventricularhem- orrhages in the premature newborn: update on pathologic features, pathogenesis and possible means of prevention. Arch Neurol 1984; 41: 766-771.
203. Burstein, J., Papile, L., Burstein, R. Subependymal germinal matrix and intraventricular hemorrhage in premature infants: diagnosis by CT. Am J Roentgenol 1977; 128: 9716.
204. Volpe, J. J. Neonatal intraventricular hemorrhage. N Engl J Med 1981; 304: 886-891.
205. Ment, L. R., Duncan, C. C., Ehrenkranz, R. A. Intraventricular hemorrhage of the preterm neonate. Semin Perinatol 1987; 11:132-141.
206. Hambleton, G., Wigglesworth, J.S. Origin of intraventricular haemorrhage in the preterm infant. Arch Dis Child 1976;51: 651-659.
207. Szymonowicz, W., Yu, V. Y. Timing and evolution of periven- tricular haemorrhage in infants weighing 1250 g or less at birth. Arch Dis Child 1984; 59:7-12.
208. Szymonowicz, W., Yu, V. Y., Wilson, F. E. Antecedents of periventricular haemorrhage in infants weighing 1250 g or lessat birth. ArchDis Child 1984; 59:13-17.
209. Lipscomb, A. P., Thorburn, R. J., Reynolds, E. O., etal. Pneumothorax and cerebral haemorrhage in preterm infants. Lancet 1981; 1:414-416.
210. Clark, C. E., Clyman, R. I., Roth, R. S., etal. Risk factor analysis of intraventricular hemorrhage in low-birth-weight infants. J Pediatr 1981; 99: 625-628.
211. Kosmetatos, N., Dinter, C., Williams, M. L., Lourie, H., Berne, A. S. Intracranial hemorrhage in the premature: its predictive features and outcome. Am J Dis Child 1980; 134: 855-859.
212. Cooke, R. W. Factors associatedwith periventricular haemorrhage in very lowbirthweight infants. Arch Dis Child 1981; 56: 425-431.
213. Dykes, F. D., Lazzara, A., Ahmann, P, et al. Intraventricular hemorrhage: a prospective evaluation of etiopathogenesis. Pediatrics 1980; 66: 42-49.
214. Andrew, M., Castle, Y, Saigal, S., Carter, C., Kelton, J. G. Clinical impact of neonatal thrombocytopenia. J Pediatr 1987; 110: 457-464.
215. Gray, O. P, Ackerman, A., Fraser, A. J. Intracranial haemorrhage and clotting defects in low-birth-weight infants. Lancet 1968; 1:545-548.
216. Vohr, B., Ment, L. R. Intraventricular hemorrhage in the preterm infant. Early Hum Dev 1996; 44:1-16.
217. Gronlund, J. U., Korvenranta, H., Kero, P, Jalonen, J., Vali-maki, I.A. Elevatedarterialbloodpressureisassociatedwith peri-intraventricular haemorrhage. Eur J Pediatr 1994;153: 836-841.
218. Kluckow, M., Evans, N. Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Arch Dis Child Fetal Neonatal Ed 2000; 82: F188-F194.
219. Morales, W. J., Angel, J. L., O’Brien, W. F., Knuppel, R. A., Marsalisi, F. The use of antenatal vitamin K in the prevention of early neonatal intraventricular hemorrhage. Am J Obstet Gynecol 1988; 159: 774-779.
220. Pomerance, J. J., Teal, J. G., Gogdok, J. F., Brown, S., Stewart, M. E. Maternallyadministered antenatalvitamin K1: effect on neonatal prothrombin activity, partial thromboplastin time, and intraventricular hemorrhage. Obstet Gynecol 1987; 70:235-241.
221. Kazzi, N. J., Ilagen, M. B., Liang, K. C. Maternal administration of vitamin K does not improve the coagulation profile of preterm infants. Pediatrics 1989; 84:1045-1050.
222. Shirahata, A., Nakamura, T., Shimono, M., Kaneko, M., Tanaka, S. Blood coagulation findings and the efficacy of factorXIII concentrate in premature infants with intracranial hemorrhages. Thromb Res 1990; 57:755-763.
223. Brangenberg, R., Bodensohn, M., Burger, U. Antithrombin III substitution in preterm infants: effects on intracranial hemorrhage and coagulation parameters. Biol Neonate 1997; 72: 76-83.
224. Andrew, M., Caco, C., Vegh, P, etal.Arandomized controlled trial of platelet transfusions in thrombocytopenic premature infants. JPediatr 1993; 123: 285-291.
225. Hensey, O. J., Morgan, M. E., Cooke, R. W. Tranexamic acid in the prevention of periventricular hemorrhage. Arch Dis Child 1984; 59:719-721.
226. Cooke, R. W., Morgan, M. E. Prophylactic ethamsylate for periventricular haemorrhage. Arch Dis Child 1984; 59: 8283.
227. Benson, J. W. T., Drayton, M. R., Hayward, C. Multicentre trial of ethamsylate for prevention of periventricular haemorrhage in very low birthweight infants. Lancet 1986; 2: 1297-1300.
228. Ment, L. R., Duncan, C. C., Ehrenkranz, R. A. Randomized low dose indomethacin trial for prevention of intraventric- ularhemorrhageinverylowbirthweightneonates.JPediatr 1988; 112:948-955.
229. Hanigan, W. C., Kennedy, G., Roemisch, F., etal.Administration of indomethacin for the prevention of periventricular- intraventricular hemorrhage in high-risk neonates. J Pediatr 1988; 112: 941-947.
230. Rennie, J. M., Doyle, J., Cooke, R. W. Early administration of indomethacin to preterm infants. Arch Dis Child 1986; 61: 233-238.
231. Schmidt, B., Andrew, M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995; 96: 939-943.
232. Nowak-Gottl, U., von Kries, R., Gobel, U. Neonatal symptomatic thromboembolism in Germany: two year survey. ArchDis Child 1997; 76: F163-F167.
233. Debus, O., Koch, H. G., Kurlemann, G., etal. Factor V Leiden and genetic defects of thrombophilia in childhood porencephaly. Arch Dis Child Fetal Neonatal Ed 1998;78: F121-F124.
234. Melegh, B., Stankovics, J., Kis, A., etal. Increased prevalence of factor V Leiden mutation in neonatal intracranial haemorrhage. Eur JPediatr 1998; 157: 261.
235. Esmon, C. T. The protein C anticoagulant pathway. Arterioscler Thromb 1992; 12:135-145.
236. Esmon, C. T. Molecular events that control the protein C anticoagulant pathway. Thromb Haemost 1993; 70: 29-35.
237. Dahlback, B. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb Res 1995; 77: 1-43.
238. Dahlback, B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 1995; 85: 607-614.
239. Van der Meer, F. J., Koster, T., Vandenbroucke, J. P, Briet, E., Rosendaal, F. R. The Leiden Thrombophilia Study (LETS). Thromb Haemost 1997; 78: 631-635.
240. Price, D. T., Ridker, P. M. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Annlntern Med 1997; 127: 895-903.
241. Seligsohn, U., Zivelin, A. Thrombophilia as a multigenic disorder. Thromb Haemost 1997; 78:297-301.
242. Nowak-Gottl, U., Binder, M., Dubbers, A., et al. Arg506 to Gln mutation in the factor V gene causes poor fibrinolytic response in children after venous occlusion. Thromb Haemost 1997; 78:1115-1118.
243. Simioni, P., Sanson, B. J., Prandoni, P, et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999; 81: 198-202.
244. Nowak-Gottl, U., Koch, H. G., Aschka, I., et al. Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haematol 1996; 92: 992-998.
245. Pipe, S. W., Schmaier, A. H., Nichols, W. C., et al. Neonatal purpura fulminans in association with factor V R506Q mutation. JPediatr 1996; 128: 706-709.
246. Gurgey, A., Mesci, L., Renda, Y., et al. Factor V Q 506 mutation in children with thrombosis. Am J Hematol 1996; 53: 37-39.
247. Kodish, E., Potter, C., Kirschbaum, N. E., Foster, P A. Activated protein C resistance in a neonate with venous thrombosis. J Pediatr 1995; 127: 645-648.
248. Haffner, D., Wuhl, E., Zieger, B., et al. Bilateral renal venous thrombosis in a neonate associated with resistance to activated protein C. Pediatr Nephrol 1996;10:737-739.
249. Pohl, M., Zimmerhackl, B., Heinen, F., et al. Bilateral renal vein thrombosis and venous sinus thrombosis in a neonate with FVmutation (FVLeiden). J Pediatr 1998; 132:159-161.
250. Poort, S. R., Rosendaal, F. R., Reitsma, P. H., Bertina, R. M. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
251. Young, G., Krohn, K. A., Packer, R. J. Prothrombin G20210A mutation in a child with spinal cord infarction. J Pediatr 1999; 134: 777-779.
252. Stier, C., Potzsch, B., Muller-Berghaus, G., Soergel, M., Klaus, G. Severe thrombophilia in a paediatric patient with end- stage renal disease: detection of the prothrombin gene G20210A mutation. Nephrol Dial Transplant 1998;13:2130-2132.
253. Lane, D.A., Caso, R.Antithrombin: structure, genomic organization, function and inherited deficiency. Baillieres Clin Haematol 1989; 2: 961-998.
254. Hirsh, J. Approach to Patients with Inherited Thrombophilia. Hamilton, Canada: B. C. Decker, 1998.
255. Bjarke, B., Herin, P, Blomback, M. Neonatal aortic thrombosis: a possible clinical manifestation of congenital antithrombin 3 deficiency. Acta Paediatr Scand 1974; 63: 297-301.
256. Schander, K., Niessen, M., Rehm, A., Budde, U., Muller, N. Diagnose und Therapie eines kongenitalen Antithrombin III Mangels in der neonatalen Periode. Blut 1980; 40: 68.
257. Winter, J. H., Fenech, A., Ridley, W., etal.Familial antithrombin III deficiency. QJMed 1982; 51: 373-395.
258. Brenner, B., Fishman, A., Goldsher, D., Schreibman, D., Tavory, S. Cerebral thrombosis in a newborn with a congenital deficiency of antithrombin III. Am J Hematol 1988; 27: 209-211.
259. Peeters, S., Vandenplas, Y., Jochmans, K., et al. Myocardial infarction in a neonate with hereditary antithrombin III deficiency. Acta Paediatr 1993; 82: 610-613.
260. Jochmans, K., Lissens, W., Vervoort, R., etal. Antithrombin-Gly 424 Arg: a novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis. Blood 1994; 83:146-151.
261. Soutar, R., Marzinotto, V, Andrew, M. Overtight nappy precipitating thrombosis in antithrombin III deficiency. Arch DisChild 1993; 69:599.
262. Newman, R. S., Spear, G. S., Kirschbaum, N. Postmortem DNA diagnosis of factor V Leiden in a neonate with systemic thrombosis and probable antithrombin deficiency. Obstet Gynecol 1998; 92: 702-705.
263. Bauer, K. Rare hereditarycoagulation factor abnormalities. In Nathan, D. G., Oski, F. A., eds. HematologyofInfancy and Childhood. Philadelphia: W. B. Saunders, 1998:1660-1675.
264. Chowdhury, V., Lane, D. A., Mille, B., et al. Homozygous antithrombin deficiency: report of two new cases (99 Leu to Phe) associated with arterial and venous thrombosis. Thromb Haemost 1994; 72:198-202.
265. Olds, R. J., Lane, D. A., Ireland, H., et al. Novel point mutations leading to type 1 antithrombin deficiency and thrombosis. Br J Haematol 1991; 78: 408-413.
266. Hakten, M., Deniz, U., Ozbay, G., Ulutin, O. N. Two cases of homozygous antithrombin III deficiency in a family with congenital deficiency of ATIII. In Senzinger, H., Vinazzer, H., eds. Thrombosis and Haemorrhagic Disorders: Proceedings of the 6th International Meeting of the Danubian League Against Thrombosis and Haemorrhagic Disorders. Wuerzburg, Germany: Schmitt and Meyer, 1989: 177.
267. Vidaud, D., Sirieix, M. E., Alhenc-Gelas, M. A double heterozygosity in 2 brothers with antithrombin (ATIII) defi- ciencydue to the association of Arg 47 to His mutation with a9base pair (bp) deletioninexonVI. Thromb Haemost 1991; 65: 838-839.
268. Shiozaki, A., Arai, T., Izumi, R., Niiya, K., Sakuragawa, N. Congenital antithrombin III deficient neonate treated with antithrombin III concentrates. Thromb Res 1993; 70: 211-216.
269. Bovill, E. G., Bauer, K. A., Dickerman, J. D., Callas, P, West, B. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 1989; 73:712-717.
270. Allaart, C. F., Poort, S. R., Rosendaal, F. R., etal. Increased risk of venous thrombosis in carriers of hereditary protein C deficiencydefect. Lancet 1993; 341:134-138.
271. De Stefano, V., Finazzi, G., Mannucci, P. M. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 1996; 87: 3531-3544.
272. De Stefano, V., Leone, G., Mastrangelo, S., etal.Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patientswithcongenitaldeficiencyof antithrombinIII, pro- tein C, protein S. Thromb Haemost 1994; 72:352-358.
273. DeVeber, G., Monagle, P, Chan, A. K. C., etal.Prothrombotic disordersininfantsandchildrenwithcerebralthromboem- bolism. Arch Neurol 1998; 55: 1539-1543.
274. Nowak-Gottl, U., Strater, R., Dubbers, A., Oleszuk-Raschke, K., Vielhaber, H. Ischaemic stroke in infancy and childhood: role of the Arg506 to Gln mutation in the factor V gene. Blood Coagul Fibrinolysis 1996; 7: 684-688.
275. Vielhaber, H., Ehrenforth, S., Koch, H. G., et al. Cerebral venous sinus thrombosis in infancy and childhood: role of genetic and acquired risk factors of thrombophilia. Eur J Pediatr 1998; 157: 555-560.
276. Uttenreuther-Fischer, M. M., Vetter, B., Hellmann, C., et al. Paediatric thrombo-embolism: the influence of nongenetic factors and the role of activated protein C resistance and protein C deficiency. Eur J Pediatr 1997; 156:277-281.
277. Toumi, N. H., Khaldi, F, Ben Becheur, S., etal. Thrombosis in congenital deficiencies of AT III, protein C or protein S: a study of 44 children. Hematol Cell Ther 1997; 39:295-299.
278. Auletta, M. J., Headington, J. T. Purpura fulminans: a cutaneous manifestation of severe protein C deficiency. Arch Dermatol 1988; 124:1387-1391.
279. Adcock, D. M., Brozna, J., Marlar, R. A. Proposed classification and pathologic mechanisms of purpura fulminans and skin necrosis. Semin Thromb Hemost 1990; 16: 333-340.
280. Adcock, D. M., Hicks, M. J. Dermatopathology of skin necrosis associated with purpurafulminans.Semin Thromb Hemost 1990; 16: 283-292.
281. Alessi, M. C., Aillaud, M. F, Paut, O., et al. Purpura fulmi-nans in a patient homozygous for a mutation in the protein C gene: prenatal diagnosis in a subsequent pregnancy. Thromb Haemost 1996; 75: 525-526.
282. Marlar, R. A., Montgomery, R. R., Broekmans, A. W. Report on the diagnosis and treatment of homozygous protein C deficiency:reportOf theWorkingPartyonHomozygousPro- tein C Deficiency of the ICTH-Subcommittee on Protein C and Protein S. Thromb Haemost 1989; 61: 529-531.
283. Dreyfus, M., Magny, J. F, Bridey, F, et al. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 1991; 325:1565-1568.
284. Monagle, P, Andrew, M., Halton, J., et al. Homozygous protein C deficiency: description of a new mutation and successful treatment with low molecular weight heparin. ThrombHaemost 1998; 79: 756-761.
285. Walker, F. J. Regulationof activatedproteinC by a newprotein: a possible function for bovine protein S. J Biol Chem 1980; 255: 5521-5524.
286. Moalic, R, Gruel, Y., Body, G., et al. Levels and plasma distribution of free and C4b-BP-bound protein S in human fetuses and full-term newborns. Thromb Res 1988; 49:471-480.
287. Schwarz, H. P., Muntean, W., Watzke, H., Richter, B., Griffin, J. H. Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates. Blood 1988;71:562-565.
288. Engesser, L., Broekmans, A. W., Briet, E., Brommer, E. J., Bertina, R. M. Hereditary protein S deficiency: clinical manifestations. Annlntern Med 1987; 106: 677-682.
289. De Stefano, V, Leone, G., Ferrelli, R., etal. Severe deep vein thrombosis in a 2-year-old child with protein S deficiency. Thromb Haemost 1987; 58: 10-89.
290. Simioni, P, Zanardi, S., Saracino, A., Girolami, A. Occurrence of arterial thrombosis in a cohort of patients with hereditary deficiency of clotting inhibitors. J Med 1992; 23: 61-74.
291. Pegelow, C. H., Ledford, M. Severe protein S deficiency in a newborn. Pediatrics 1992; 89: 674-675.
292. Gomez, E., Ledford, M. R., Pegelow, C. H., Reitsma, P. H., Bertina, R. M. Homozygous protein S deficiency due to a one base pair deletion that leads to a stop codon in exon III of the protein S gene. Thromb Haemost 1994; 71:723-726.
293. Marlar, R. A., Neuman, A. Neonatal purpura fulminans due to homozygous protein C or protein S deficiences. Semin Thromb Hemost 1990; 16: 299-309.
294. Mahasandana, C., Suvatte, V., Chuansumrit, A., et al. Homozygous protein S deficiency in an infant with purpura fulminans. J Pediatr 1990; 117: 750-753.
295. Mahasandana, C., Suvatte, V, Marlar, R. A., et al. Neonatal purpura fulminans associated with homozygous protein S deficiency. Lancet 1990; 335: 61-62.
296. Hui, C. H., Lam, C. C., Sze, C. S. A family of protein S deficiency including two adults with homozygous deficiency. Thromb Haemost 1997; 78:1158-1159.
297. Mahasandana, C., Veerakul, G., Tanphaichitr, V S., et al. Homozygous protein S deficiency: 7-year follow-up. Thromb Haemost 1996; 76:1122.
298. Mintz-Hittner, H. A., Miyashiro, M.J., Knight-Nanan, D. M., O’Malley, R. E., Marlar, R. A. Vitreoretinal findings similar to retinopathy of prematurity in infants with compound heterozygous protein S deficiency. Ophthalmology 1999; 106: 1525-1530.
299. Pung-amritt, P, Poort, S. R., Vos, H. L., et al. Compound heterozygosity for one novel and one recurrent mutation in a Thai patient with severe protein S deficiency. Thromb Haemost 1999; 81: 189-192.
300. Fletcher, M. A., Brown, D. R., Landers, S., Seguin, J. Umbilical arterial catheter use: report of an audit conducted by the Study Group for Complications of Perinatal Care. Am J Perinatol 1994; 11: 94-99.
301. Lott, J., Connor, G., Phillips, J. Umbilical artery catheter blood sampling alters cerebral blood flow velocity in preterm infants. J Perinatol 1996; 16:341-345.
302. Rand, T., Weninger, M., Kohlhauser, C. Effect of umbilical artery catheterization in mesenteric hemodynamics. Pediatr Radiol 1996; 26: 435-438.
303. Schmidt, B., Andrew, M. Neonatal thrombotic disease: prevention, diagnosis, and treatment. JPediatr 1988; 113:407-410.
304. Raval, N. C., Gonzalez, E., Bhat, A. M., Pearlman, S. A., Stefano, J. L. Umbilical venous catheters: evaluation of radiographs to determine position and associated complications of malpositioned umbilical venous catheters. Am J Perinatol 1995; 12: 201-204.
305. Schwartz, D. S., Gettner, P. A., Konstantino, M. M., et al. Umbilical venous catheterization and the risk of portal vein thrombosis. JPediatr 1997; 131: 760-762.
306. Obladen, M., Ernst, D., Feist, D., Wille, L. Portal hypertension in children following neonatal umbilical disorders. J Perinat Med 1975; 3: 101-104.
307. Tizard, J. P M. Portal hypertension following exchange transfusion through the umbilical vein. Proc Soc Exp Biol Med 1962; 55: 772.
308. Thompson, E. M., Sherlock, S. The aetiology of portal vein thrombosis with particular reference to the role of infection and exchange transfusion. QJMed 1964; 33:465.
309. Vos, L. J., Potocky, V, Broker, F. H., et al. Splenic vein thrombosis with oesophageal varices: a late complication of umbilical vein catheterization. Ann Surg 1974; 180:152-156.
310. Evans, D. J., Silverman, M., Bowley, N. B. Congenital hypertension due to unilateral renal vein thrombosis. Arch Dis Child 1981; 56: 306-308.
311. Massicotte, M. P., Dix, D., Monagle, P., Adams, M., Andrew, M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. JPediatr 1998; 133: 770-776.
312. Marie, I., Levesque, H., Cailleux, N., et al. Deep venous thrombosis of the upper limbs: a propos of 49 cases. Rev Medlnterne 1998; 19: 399-408.
313. Mulvihill, S. J., Fonkalsrud, E. W. Complications of superior versus inferior vena cava occlusion in infants receiving central total parenteral nutrition. J Pediatr Surg 1984; 19:752-757.
314. Rockoff, M. A., Gang, D. L., Vacanti, J. P. Fatal pulmonary embolism following removal of a central venous catheter. J Pediatr Surg 1984; 19: 307-309.
315. Derish, M. T., Smith, D. W., Frankel, L. R. Venous catheter thrombus formation and pulmonaryembolism in children. Pediatr Pulmonol 1995; 20: 349-354.
316. Ament, J., Newth, C. J. Deep venous lines and thromboembolism. Pediatr Pulmonol 1995; 20: 347-348.
317. Andrew, M., David, M., Adams, M., et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994; 83: 1251-1257.
318. Monagle, P, Adams, M., Mahoney, M., et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000; 47: 763-766.
319. Nuss, R., Hays, T., Manco-Johnson, M. Efficacy and safety of heparin anticoagulation for neonatal renal vein thrombosis. Am J Pediatr Hematol Oncol 1994; 16:127-131.
320. Hibbert, J., Howlett, D. C., Greenwood, K. L., MacDonald, L. M., Saunders, A. J. The ultrasound appearances of neonatal renal vein thrombosis. Br J Radiol 1997;70:1191-1194.
321. Pohl, M., Zimmerhackl, L. B., Hausser, I., etal.Acute bilateral renal vein thrombosis complicating Netherton syndrome. Eur J Pediatr 1998; 157:157-160.
322. Gonzalez, R., Schwartz, S., Sheldon, C. A., Fraley, E. E. Bilateral renal vein thrombosis in infancy and childhood. Urol Clin North Am 1982; 9: 279-283.
323. Mocan, H., Beattie, T. J., Murphy, A. Renal venous thrombosis in infancy: long-term follow-up. Pediatr Nephrol 1991; 5: 45-49.
324. Leblanc, J. G., Culham, J. A., Chan, K. W., et al. Treatment of grafts and major vessel thrombosis with low-dose streptokinase in children. Ann Thorac Surg 1986; 41:630-635.
325. Metreweli, C., Pearson, R. Echographic diagnosis of neona- tal renal venous thrombosis. Pediatr Radiol 1984; 14:105-108.
326. Nazer, H., Rajab, A. A., Qaryouti, S., etal.Neonatal limb gangrene and renalvein thrombosis: case report with review of literature. Eur J Pediatr 1987; 146:429-431.
327. Munoz-Anizpe, R., Walsh, R. F., Edge, W. Obstructive aortic and renal thrombosis in the newborn-spontaneous recovery. Pediatr Nephrol 1992; 6:190-191.
328. Tinaztepe, K., Buyan, N., Tinaztepe, B., Akkok, N. The asso- ciationof nephrotic syndrome and renalvein thrombosis: a clinicopathologicalanalysisof eightpediatricpatients. Turk J Pediatr 1989; 31:1-8.
329. Starinsky, R., Graif, M., Lotan, D., Kessler, A. Thrombus calcification of renal vein in neonate: ultrasound and CT diagnosis. JComputAssist Tomogr 1989; 13:545-546.
330. Thompson, I. M., Schneider, R., Lababidi, Z. Thrombectomy for neanatal renal vein thrombosis. J Urol 1975; 113: 396-399.
331. Renfield, M. L., Kraybill, E. N. Consumptive coagulopathy with renalvein thrombosis. JPediatr 1973; 82:1054-1056.
332. Oliver, W. J., Kelsch, R. C. Renal venous thrombosis in infancy. Pediatrics Rev 1982; 4: 61-66.
333. Seeler, R.A., Kapadia, P, Moncado, R. Nonsurgical manage- mentofthrombosisof bilateralrenalveinsandinferiorvena cava in a newborn infant. Clin Pediatr 1970; 9: 543-547.
334. Lowry, M. F., Mann, J. R., Abrams, L. D., Chance, G. W. Thrombectomy for renal venous thrombosis in infant of diabetic mother. BrMed J 1970;3:687.
335. Fielding, G. A., Masel, J., Leditschke, J. F. Spontaneous neonatal renal vein thrombosis. Aust N Z J Surg 1986; 56: 485-488.
336. Belman, A. B., Susmano, D. F., Burden, J. J., Kaplan, G. W. Nonoperative treatment of unilateral renal vein thrombosis in the newborn. J Am Med Assoc 1970; 211: 1165-1168.
337. Cozzolino, D. J., Cendron, M. Bilateral renal vein thrombosis in a newborn: a case of prenatal renal vein thrombosis. Urology 1997; 50: 128-131.
338. Duncan, B., Adzick, N. S., Longaker, M., et al. In utero arterial embolism from renal vein thrombosis with successful postnatal thrombolytic therapy. J PediatrSurg 1991; 26: 741-743.
339. Sanders, L., Jequier, S. Ultrasound demonstration of prenatal renal vein thrombosis. Pediatr Radiol 1989; 19: 133-135.
340. Lalmand, B., Avni, E. F., Nasr, A., Ketelbant, P., Struyven, J. Perinatal renal vein thrombosis. J Ultrasound Med 1990; 9: 437-442.
341. Al-Samarrai, S. F., Kato, A., Urano, Y. Renalveinthrombosis in stillborn infant of diabetic mother. Acta Pathol Jpn 1984; 34: 1441-1447.
342. Tekinalp, G., Oran, O., Erturk, G., Yetgin, S. Renalandaxillary thrombosis in an infant of a diabetic mother. Turk J Pediatr 1986; 28:191-194.
343. Glassock, R. J., Duffy, J., Kodroff, M. B., Chan, J. C. Dehydra- tion, renalveinthrombosis, and hyperkalemicrenaltubular acidosis in a newborn. Am JNephrol 1983; 3:329-337.
344. Newton, T. H., Gooding, C. A. Compression of superior sagittal sinus by neonatal calvarial molding. Neuroradiology 1975; 115:635-639.
345. DeVeber, G., Andrew, M. Canadian pediatric ischemic stroke Registry: analysis I. PediatrRes 1994; 35:379A.
346. Rivkin, M. J., Anderson, M. L., Kaye, E. M. Neonatal idiopathic cerebral venous thrombosis: an unrecognized cause of transient seizuresorlethargy. AnnNeurol 1992; 32:51-56.
347. Shevell, M. I., Silver, K., O’Gorman, A. M., Watters, G. V, Montes, J. L. Neonatal dural sinus thrombosis. Pediatr Neurol 1989; 5:161-165.
348. Barron, T. F., Gusnard, D. A., Zimmerman, R. A., Clancy, R. R. Cerebral venous thrombosis in neonates and children. Pediatr Neurol 1992; 8: 112-116.
349. Hartmann, A., Wappenschmidt, J., Solymosi, L., Brassel, J. Clinical findings and differential diagnosis of cerebral vein thrombosis. In Einhaupl, K., ed. CerebralSinus Thrombosis: Experimental and Clinical Aspects.NewYork: PlenumPress, 1987:171-185.
350. Zimmerman, R. A., Bogdan, A. R., Gusnard, D. A. Pediatric magnetic resonance angiography: assessment of stroke. Cardiovasc Intervent Radiol 1992; 15: 60-64.
351. Macchi, PJ., Grossman, R. I., Gomori, J. M., etal. High field MRimagingof cerebralvenousthrombosis.J Comput Assist Tomogr 1986; 10:10-15.
352. Medlock, M. D., Olivero, W. C., Hanigan, W. C., Wright, R. M., Winek, S. J. Children with cerebral venous thrombosis diagnosed with magnetic resonance imaging and magnetic resonance angiography. Neurosurgery 1992; 31: 870-876.
353. Bezinque, S. L., Slovis, T. L., Touchette, A. S., etal.Character- ization of superior sagittal sinus blood flow velocity using color flow Doppler in neonates and infants. Pediatr Radiol 1995; 25:175-179.
354. Andrew, M., Of osu, F., Schmidt, B., etal. Heparinclearance and ex vivo recovery in newborn piglets and adult pigs. Thromb Res 1988; 52: 517-527.
355. McDonald, M. M., Jacobson, L. J., Hay, W. W., Hathaway, W. E. Heparin clearance in the newborn. Pediatr Res 1981; 15: 1015-1018.
356. Turner Gomes, S., Nitschmann, E., Benson, L., Burrows, P., Andrew, M. Heparin is cleared faster in children with congenital heart disease thanadults. JAm Coll Cardiol 1993; 21: 59a.
357. Hirsh, J. Heparin. N Engl JMed 1991; 324:1565-1574.
358. Andrew, M., Marzinotto, V., Massicotte, P., et al Heparin therapy in pediatric patients: a prospective cohort study. PediatrRes 1994; 35: 78-83.
359. Cruickshank, M. K., Levine, M. N., Hirsh, J., Roberts, R., Siguenza, M. A standard heparin nomogram for the management of heparin therapy. ArchIntern Med 1991; 151:333-337.
360. Hirsh, J., Levine, M. Low molecular weight heparin. Blood 1992; 79:1-7.
361. Weitz, J. I. Low molecular weight heparins. N Engl J Med 1997; 337: 688-698.
362. Massicotte, M. P., Marzinotto, V, Julian, J., etal. Dose finding and pharmacokinetics of prophylactic doses of a low molecular weight heparin (reviparinTM) in pediatric patients. Blood 1999; 94 (Suppl 1): 27a.
363. Massicotte, P., Adams, M., Marzinotto, V, Brooker, L. A., Andrew, M. Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr 1996; 128: 313-318.
364. Massicotte, M. P., Adams, M., Leaker, M., Andrew, M. A nomogram to establish therapeutic levels Of the lowmolec- ular weight heparin (LMWH), clivarine in children requir- ingtreatmentforvenous thromboembolism (VTE). Thromb Haemost 1997; (Suppl): 282.
365. Hathaway, W., Corrigan, J. Report of Scientific and Standardization Subcommittee on Neonatal Hemostasis: normal coagulation data for fetuses and newborn infants. Thromb Haemost 1991; 65: 323-325.
366. Andrew, M., Mitchell, L., Vegh, P., Of osu, F. Thrombin regulation in children differs from adults in the absence and presence of heparin. Thromb Haemost 1994; 72: 836-842.
367. Schmidt, B., Andrew, M. Report of Scientific and Standardization Subcommittee on Neonatal Hemostasis Diagnosis and Treatment of Neonatal Thrombosis. Thromb Haemost 1992; 67: 381-382.
368. Bovill, E. G., Soll, R., Lynch, M., etal.Vitamin K1 metabolism and the production of des-carboxy prothrombin and protein C in the term and premature neonate. Blood 1993; 81: 77-83.
369. Haroon, Y., Shearer, M. J., Rahim, S., et al. The content of phylloquinone (vitamin K1) in human milk, cow’s milk and infant formula foods determined by high-performance liquid chromatography. J Nutr 1982; 112:1105-1117.
370. VonKries, R., Shearer, M. J., McCarthy, P T., etal. Vitamin K1 content of maternal milk: influence of the stage of lactation, lipid composition, and vitamin K1 supplements given to the mother. Pediatr Res 1987; 22: 513-517.
371. Lehman, M., Kolb, K., Barnhart, G. R., Wagman, L., Barr, W. H. Warfarin absorption in a patient with short-bowel syndrome. Clin Pharm 1985; 4: 325-326.
372. Corrigan, J. J., Jr, Sleeth, J. J., Jeter, M., Lox, C. D. Newborn’s fibrinolytic mechanism: components and plasmin generation. Am J Hematol 1989; 32: 273-278.
373. Andrew, M., Brooker, L., Leaker, M., Paes, B., Weitz, J. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration. Thromb Haemost 1992; 68: 325-330.
374. Leaker, M., Superina, R., Andrew, M. Fibrin clot lysis by tissue plasminogen activator (tPA) is impaired in plasma from pediatric liver transplant patients. Transplantation 1995; 60:144-147.
375. Zenz, W., Arlt, F., Sodia, S., Berghold, A. Intracerebral hemorrhage during fibrinolytic therapy in children: a review of the literature of the last thirty years. Semin ThrombosHaemost 1997; 23:321-332.
376. Bovill, E. G., Becker, R., Tracy, R. P. Monitoring thrombolytic therapy. Progr Cardiovasc Dis 1992; 34: 279-294.
377. Andrew, M., Brooker, L. A. Blood component therapy in neonatal hemostatic disorders. [Published erratum appears in Transfus Med Rev 1996; 10: 248] Transfus Med Rev 1995; 9: 231-250.
378. Monagle, P., Chan, A., Massicotte, P., Chalmers, E., Michelson, A. D.Antithrombictherapy in children.Chest 2004;126: 6455-6875.
379. Michelson, A. D., Bovill, E., Monagle, P., Andrew, M. Antithrombotic therapy in children. Chest 1998; 114:748S-769S.